Robert Chapkin, Ph.D., Distinguished Professor in the Texas A&M University - Department of Nutrition, is part of a team of Texas A&M University researchers who received a $2.3 million grant from the National Institutes of Health (NIH) to explore a unique immunotherapy that could be the first of its kind to treat colon cancer. The collaborative, four-year project will determine how to best utilize a new class of drugs developed in the laboratory of Stephen Safe, Ph.D., Distinguished Professor in Texas A&M School of Veterinary Medicine & Biomedical Sciences. Ultimately, Safe believes these drugs could also mitigate other types of cancer, including breast cancer, glioblastoma and rhabdomyosarcoma, which affects children. Read more about this research at tx.ag/CancerDrug. -- Texas A&M University Department of Biochemistry and Biophysics | Texas A&M AgriLife #cancercure #cancerresearch #findacure